Versant Venture Capital VI, L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 17,322 shares at $19.58 ($339K) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $339k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.58 | 7,651 | $150K | 44.2% |
| 2 | $19.58 | 7,651 | $150K | 44.2% |
| 3 | $19.50 | 2,020 | $39K | 11.6% |
| Total | $19.57 avg | 17,322 | $339K | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |